APA (7th ed.) Citation

Jarius, S., Ringelstein, M., Schanda, K., Ruprecht, K., Korporal-Kuhnke, M., Viehöver, A. M., . . . Wildemann, B. (2024). Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: Exclusive or predominant MOG-IgG3 seropositivity : a potential diagnostic pitfall in patients with MOG-EM/MOGAD. Journal of neurology, 271(7), . https://doi.org/10.1007/s00415-024-12285-5

Chicago Style (17th ed.) Citation

Jarius, Sven, et al. "Improving the Sensitivity of Myelin Oligodendrocyte Glycoprotein-antibody Testing: Exclusive or Predominant MOG-IgG3 Seropositivity : A Potential Diagnostic Pitfall in Patients with MOG-EM/MOGAD." Journal of Neurology 271, no. 7 (2024). https://doi.org/10.1007/s00415-024-12285-5.

MLA (9th ed.) Citation

Jarius, Sven, et al. "Improving the Sensitivity of Myelin Oligodendrocyte Glycoprotein-antibody Testing: Exclusive or Predominant MOG-IgG3 Seropositivity : A Potential Diagnostic Pitfall in Patients with MOG-EM/MOGAD." Journal of Neurology, vol. 271, no. 7, 2024, https://doi.org/10.1007/s00415-024-12285-5.